Yahoo Web Search

  1. Sort by

  1. Press Release

    PharmiWebMay 17 05:13 AM

    BrainStorm Cell Therapeutics Inc. Posted on: 17 May 16 HACKENSACK, N.J. and PETACH TIKVAH, Israel, May 17, 2016/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that Chaim Lebovits, Chief Executive Officer, will be presenting Thursday, May 19th, at the 11th World Stem Cells ...

  2. HACKENSACK, N.J. and PETACH TIKVAH, Israel , May 17, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, ...

  3. As expected, the company reported no revenues for the quarter. The company exited the first quarter of 2016 with cash and short-term investments of $12.9 million. As of May 6, 2016 the company had approximately 18.7 million shares outstanding.

  4. HACKENSACK, N.J. and PETACH TIKVAH, Israel, May 10, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, ...

  5. HACKENSACK, N.J. and PETACH TIKVAH, Israel, May 10, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the first...

  6. HACKENSACK, N.J. and PETACH TIKVAH, Israel, May 12, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that its wholly-owned subsidiary, Brainstorm Cell Therapeutics Ltd., has been awarded a new grant of approximately $1,470,000 from Israel's Office of the Chief Scientist (OCS). This ...

  7. Next-Generation Biologics Market 2016-2026

    PR Newswire via Yahoo! FinanceMay 20 06:00 AM

    LONDON, May 20, 2016 /PRNewswire/ -- - Revenue Forecasts And R&D Trends for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine - Emerging ...

  1. Ad
    related to Brainstorm Cell Therapeutics
  1. 7 results